BactInflam bandeau_image 300x1383

Presentation

Presentation BactInflam

Beneficial bacteria (propionic acid-, lactic acid- or commensal- bacteria), and compounds thereof, could serve as complements or alternatives to current anti-IBD treatments and to antibiotics used in prevention and treatment of mastitis.

International Joint Laboratory  (Laboratoire International Associé / LIA)

Bact-Inflam - INRA-UFMG

Brazilian and French BactInflam partners have been collaborating since 2000.
They co-authored together 90+ scientific papers and book chapters.
They co-supervised 20+ PhD students and 15+ post-docs.
The LIA BactInflam label,  co-signed by INRA and UFMG, strengthens this fruitful collaboration.

collaborations

Bact-Inflam objectives

  • To identify bacterial determinants involved in pro- or anti-inflammatory processes in various context (IBD and mastitis)
  • To characterize inflammatory processes with, as a start point, our models of mammary gland and gut

Bact-Inflam strategy

  • Characterization of the inflammation process and of the bacteria involved in the inflammation (e.g. S. aureus / mastitis)
  • Determination of microbiota composition associated to inflamed or healthy organes
  • Identification of marker species (dysbiosis/inflamed or eubiosis/healthy)
  • Characterization of these biomarkers at the cellular and molecular levels
  • Validation on animal models
  • Development of new therapeutic strategies and or alternatives to allopathic treatments, based on the use of immunomodulatory bacteria or bacterial compounds.

In this rubric

Temas & Objectivos
Bactérias benéficas (bactéria comensais, ácido propiônicas ou ácido lácticas) e seus compostos podem servir como complementos ou alternativas aos atuais tratamentos anti-doenças inflamatórias intestinais (DII) e aos antibióticos usados na prevenção e tratamento da mastite.
Themes & Objectives
Beneficial bacteria (propionic acid-, lactic acid- or commensal- bacteria), and compounds thereof, could serve as complements or alternatives to current anti-IBD treatments and to antibiotics used in prevention and treatment of mastitis.
Thèmes & Objectifs
Beneficial bacteria (propionic acid-, lactic acid- or commensal- bacteria), and compounds thereof, could serve as complements or alternatives to current anti-IBD treatments and to antibiotics used in prevention and treatment of mastitis.

Modification date : 21 July 2023 | Publication date : 04 October 2018 | Redactor : bactinflam, bactinflam inra